(Q73645071)
Statements
Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study (English)
R M Elledge
S Green
R Pugh
D C Allred
G M Clark
J Hill
P Ravdin
S Martino